期刊文献+

单纯性肥胖儿童代谢综合征成份分析 被引量:3

Prevalence of metabolism syndrome in primary obese children
在线阅读 下载PDF
导出
摘要 目的探讨单纯性肥胖儿童糖代谢、脂代谢情况、血压水平及胰岛素抵抗程度。方法采用随机对照的病例研究方法,分析年龄6~13岁单纯性肥胖儿童(n=53)与非肥胖同年龄组儿童(n=40),二者空腹血糖(FPG)、胰岛素抵抗指数(IRI)、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、动脉收缩压及舒张压水平的差异。结果肥胖组儿童FPG、IRI、TG、TC、LDL-C、收缩压水平均明显高于对照组(P<0.05),HDL-C水平则低于对照组(P<0.05)。肥胖组中存在高血压者8例(15.1%),脂代谢紊乱者19例(35.8%),FPG异常者3例(5.7%);同时存在高血压、脂代谢紊乱及FPG异常中2种及(或)以上异常者10例(18.9%)。结论单纯性肥胖儿童多存在不同程度的糖、脂代谢异常及血压异常,同时存在代谢综合征成份簇集的倾向。 [Objective] To investigate the prevalence of metabolism syndrome (MS) in primary obese children. [Methods] A randomized and controlled study was designed to analyzed the difference of fasting plasma glucose (FPG), insulin resistance index(IRI), serum triglyceride (TG), total cholesterol (TC), high density hpoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), systolic blood pressure (SBP) and diastolic blood pressure between primary obese children group (n =53, aged from 6 to 13 years old) and control group (n =40). [Results] Levels of FPG, IRI, TG, TC, LDL-C and SBP were significantly higher and HDL-C level was significantly lower in obesity group in obesity group than in control group (P 〈0.05). Eight patients (15.1%) were found hypertension, 19(35.8%) were found dyslipoproteinemia and 3(5.7%) were found impaired fasting glucose in obesity group. Ten patients (18.9%) were found 2 or (and) more risk factors among hypertension, dyslipoproteinemia and impaired fasting glucose. [Conclusions] Some of primary obese children were suffered dysfunction of glycemia, blood lipid and blood pressure regulation, and even some were found been metabolism syndrome.
作者 李少存 莫蛮
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2005年第15期2329-2331,共3页 China Journal of Modern Medicine
关键词 儿童 肥胖症 代谢综合征 children obesity metabolism syndrome
  • 相关文献

参考文献11

  • 1漆泓,孙明,周宏研.吉非罗齐对代谢综合征血脂及胰岛素抵抗的影响(英文)[J].中国现代医学杂志,2004,14(17):50-53. 被引量:9
  • 2ANDERSON LB, WEDDERKOPP N, HANSEN HS, et al. Biological cardiovascular risk factors cluster in Danish children and adolescents: The European Youth Heart Study [J]. Prey Med,2003, 37(4): 363-367.
  • 3VINER Pal, SEGAL TY, LICHTAROWICZ-KRYNSKA E, et al.Prevalence of the insulin resistance syndrome in obesity [J].Archives of Dis in Childhood, 2005, 90:10-14.
  • 4World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus.Geneva[J]. World Health Organization, 1999.
  • 5CLEEMAN JI. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in aduhs(adult treatment panel Ⅲ)[J]. JAMA, 2001,285: 2486-2497.
  • 6孙志香,吴静,雷闽湘.单纯性肥胖患者血清瘦素的变化及其与胰岛素抵抗的关系[J].中国现代医学杂志,2004,14(5):126-127. 被引量:11
  • 7MECARTHY HD, ELLIS SM, COLE T. Central overweight and obesity is British youth aged 11-16 years: cross sectional surveys of waist circumference[J]. BMJ, 2003, 326: 624-627.
  • 8COWIN I, EMMETT P. Cholesterol and triglyceride concentrations, birthweight and centre obesity in pre-schcol children.ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood[J]. Int J Obes Relat Metab Disord, 2000, 24(3):330-339.
  • 9HE Q, HORLICK M, FEDUN B, et al. Trunk fat and blood pressure in children through puberty. Circulation, 2002, 105(9):1093-1098.
  • 10GORAN MI, BERGMAN RN, COWER BA. Influence of total visceral fat on insulin action and secretion in African-American and white children[J]. Obesity Research, 2001, 9: 423-431.

二级参考文献12

  • 1Kim JK, Fillmore JJ, Chen Y, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance[J]. PNAS, 2001, 98(13): 7522-7527.
  • 2Reaven GM. Role of insulin resistance in human disease[J]. Diabetes. 1988, 37: 1595-1607.
  • 3Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans [J]. J Clin Invest.1996, 97: 2859-2865.
  • 4Asplund-Carlson A. Effects of Gemfibrozil therapy on glucose tolerance, insulin sensitivity and plasma plasminogen activator inhibitor activity in hypertriglyceridaemia[J]. J Cardiovasc Risk,1996, 3(4): 385-390.
  • 5ZHU XX. The fifth lecture: insulin resistance, metabolic syndrome and insulin sensitization invigorator[J]. Zhonghua Neifenmi Daixie Zazhi, 2000,16(5):333-334. Chinese
  • 6LI GW. Some errors in current evaluation to insulin sensitivity and in researches of insulin resistance[J]. Zhonghua Neike Zazhi, 1998, 37(2): 81-83. Chinese
  • 7Avoaro A, Miola M, Favaro A, et al. Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients[J]. Eur J clin Invest, 2001, 31(7): 603-609.
  • 8Matsui H, okumura K, kawakami K, et al. Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid com position of skeletal-muscle triglycerides[J]. Diabetes, 1997, 46:348-353.
  • 9Jones IR, Suai A, Taylor R, et al. Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM[J]. Diabetes Care 1990, 13: 855-863.
  • 10Millo MG, Gervois P, Raspe E, et al. Peroxisome proliferatoractivated receptor αactivators improve insulin sensitivity and reduce adiposity[J]. J of Biol Chem, 2000, 275(22): 16638-16642.

共引文献18

同被引文献25

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部